Has Frank Sinicrope, MD received payments from drug or device companies?

Yes. Drug and device makers reported $34,594 in general payments to Frank Sinicrope, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Sinicrope, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Sinicrope, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Sinicrope, MD

Medical Oncology · Rochester, MNNPI 1144200353

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. F. Hoffmann-la Roche AG accounts for 65.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $16,199, 4.2 times the $3,899 reported in 2019.

$34,594in general payments, 2019–2025

Across 36 payments — averaging $960.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

F. Hoffmann-la Roche AG$23K
Ventana Medical Systems, Inc.$4K
GSK$4K
Eisai Inc.$3K
Roche Molecular Systems, Inc.$495
Genentech, Inc.$334
plus $240 from 1 others

$10,282,226in research payments, 2019–2025

Across 99 payments — averaging $103,861 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$10M
Ventana Medical Systems, Inc.$290K
Mallinckrodt Enterprises LLC$7K

What the payments were for

Consulting fees$17,24850%
Speaking & faculty fees$1,5004%
Travel & lodging$13,34439%
Food & beverage$2,0666%
Education$4361%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
F. Hoffmann-la Roche AG	7	$22,789
Ventana Medical Systems, Inc.	15	$4,169
GSK	2	$3,862
Eisai Inc.	2	$2,704
Roche Molecular Systems, Inc.	4	$495
Genentech, Inc.	3	$334
Genentech USA, Inc.	3	$240

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,594 in reported general payments places this provider in the 80th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$453,361

Medicare patients

185

Services billed

16,964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	14	$102
Prochlorperazine Maleate	13	$98

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

Amit MahipalRochester$746K
Alton SartorRochester$688K
Ben GeorgeRochester$579K
Elisabeth HeathRochester$236K
Matthew GoetzRochester$136K
Thorvardur HalfdanarsonRochester$86K
Harry YoonRochester$69K
Karthik GiridharRochester$66K
Joleen HubbardRochester$59K
Lionel Aurelien Kankeu FonkouaRochester$58K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →